Cite
HARVARD Citation
Kaufman, P. et al. (n.d.). Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-negative metastatic breast cancer (MBC): A Phase I open-label trial. European journal of cancer. pp. S117-S118. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kaufman, P. et al. (n.d.). Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-negative metastatic breast cancer (MBC): A Phase I open-label trial. European journal of cancer. pp. S117-S118. [Online].